catechin and Brain Vascular Disorders

catechin has been researched along with Brain Vascular Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, WJ; Han, JY; Jung, YD; Kim, JH; Kim, JK; Lee, SG; Oh, BS1
Appleton, I; Rahman, RM; Sutherland, BA1
Atsumi, T; Hara, Y; Harada, K; Iijima, H; Komagata, Y; Komiyama, K; Ohashi, K; Ohashi, T; Shimizu, T; Tateishi, M; Watanabe, H; Yamada, H1
Akashi, T; Niwa, M; Ozaki, M; Taniyama, K; Uchida, S; Yamashita, K1

Reviews

1 review(s) available for catechin and Brain Vascular Disorders

ArticleYear
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration.
    The Journal of nutritional biochemistry, 2006, Volume: 17, Issue:5

    Topics: Antioxidants; Apoptosis; Brain Ischemia; Camellia sinensis; Cardiovascular Diseases; Catechin; Cerebrovascular Disorders; Flavonoids; Free Radical Scavengers; Ischemia; Lipid Peroxidation; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Phenols; Polyphenols; Tea

2006

Trials

1 trial(s) available for catechin and Brain Vascular Disorders

ArticleYear
A randomized clinical study of tea catechin inhalation effects on methicillin-resistant Staphylococcus aureus in disabled elderly patients.
    Journal of the American Medical Directors Association, 2006, Volume: 7, Issue:2

    Topics: Administration, Inhalation; Aged; Aged, 80 and over; Catechin; Cerebrovascular Disorders; Chi-Square Distribution; Colony Count, Microbial; Disabled Persons; Drug Administration Schedule; Female; Frail Elderly; Hospitals, General; Humans; Japan; Male; Methicillin Resistance; Prospective Studies; Single-Blind Method; Sputum; Staphylococcal Infections; Staphylococcus aureus; Tea; Treatment Outcome

2006

Other Studies

2 other study(ies) available for catechin and Brain Vascular Disorders

ArticleYear
Neurorestorative effects of epigallocatechin-3-Gallate on cognitive function in a chronic cerebral hypoperfusion rat model.
    Restorative neurology and neuroscience, 2016, 04-11, Volume: 34, Issue:3

    Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cerebrovascular Disorders; Cognition Disorders; Disease Models, Animal; Drug Administration Routes; Escape Reaction; Hippocampus; Male; Malondialdehyde; Maze Learning; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Superoxide Dismutase; Vascular Endothelial Growth Factor A

2016
Effects of (-)-epigallocatechin-3-O-gallate (green tea tannin) on the life span of stroke-prone spontaneously hypertensive rats.
    Clinical and experimental pharmacology & physiology. Supplement, 1995, Volume: 22, Issue:1

    Topics: Animals; Antihypertensive Agents; Catechin; Cerebrovascular Disorders; Flavonoids; Hydrolyzable Tannins; Hypertension; Life Expectancy; Rats; Rats, Inbred SHR

1995